锦欣生殖(01951.HK)拟3月26日举行董事会会议以审批年度业绩

Core Viewpoint - The company, Jinxin Reproductive Medicine (01951.HK), has announced a board meeting scheduled for March 26, 2026, to consider and approve the annual performance for the fiscal year ending December 31, 2025 [1] Group 1 - The board meeting will focus on the approval of the group's annual results [1]